Dr John Philip O'Dwyer

Dr John Philip O’Dwyer is a highly regarded Consultant Neurologist with practices in both London and the Home Counties. He currently sees private patients at Mayo Clinic, The Lister Hospital, St John & St Elizabeth Hospital, Spire Clare Park Hospital and OSD Healthcare. He is internationally recognised for his expertise in treating conditions such as headache, migraine, epilepsy, and Botulinum toxin therapy. Additionally, he specialises in addressing issues related to dizziness, vertigo, and stroke. Dr O’Dwyer completed his medical degree at Trinity College Dublin in 1998. He then pursued advanced training in neurology, obtaining a doctorate in neuroscience and a fellowship in movement disorders. He is a Member of the Royal College of Physicians of Ireland and a Fellow of the Royal College of Physicians. Upon relocating to the United Kingdom, Dr O’Dwyer was appointed as a Consultant Neurologist at several prestigious London hospitals, including St George’s University Hospitals NHS Trust, Charing Cross Hospital and St Mary's Hospital. Notably, he also many roles at Imperial College Healthcare NHS Trust, where he eventually became the Head of Neurology (Regional Neuroscience Centre for NW London). Dr O’Dwyer is also a Consultant Neurology Advisor for the British Army and holds the rank of Officer in the Royal Army Medical Corps. His involvement with the military extends back to his officer training at the Royal Military Academy Sandhurst in 2016. He has also earned a Master’s in military leadership and business administration and management, achieving level 7 recognition in Leadership and Command in partnership with King’s College London. Dr O’Dwyer has authored numerous academic articles published in esteemed peer-reviewed journals. He is actively engaged in cutting-edge research and serves as the principal investigator for several pivotal national clinical trials related to epilepsy. Beyond his clinical work, he has lent his expertise as a specialist advisor for the NHS and the Care Quality Commission (CQC) in the development of therapeutic strategies. Dr O’Dwyer further shares his insights through a neurology blog, where he imparts valuable knowledge to a broader audience.

Epilepsy, Transient alterations of Consciousness and other Paroxysmal attacks Headache and Migraine, including new CGRP drugs Balance problems, Dizziness and Vestibular disorders Dementia and Cognitive change Multiple Sclerosis and inflammatory disorders of the CNS Stroke Parkinsons and Movement Disorders, including Dystonia Brain Tumours and CNS malignancy Botox for Dystonia, Spasticity and Migraine Spinal Cord disorders Peripheral Neuropathy